Pacific Biosciences of California, Inc. Stock: price and insider trades · United States

Pacific Biosciences of California, Inc. (NASDAQ: PACB), known commercially as PacBio, is a United States-based life-science technology company headquartered in Menlo Park, California. Founded in the early 2000s, the company built its reputation around high-accuracy genomic sequencing, with a particular focus on long-read technologies that can resolve complex genomic regions, structural variants, repeat expansions and other difficult-to-read areas that are less accessible with conventional short-read methods. PacBio has evolved from a specialist research instrument vendor into a broader sequencing platform company serving academic researchers, genome centers, public-health labs, clinical research groups and industrial customers.

PacBio’s business model centers on the design, development and commercialization of sequencing systems, consumables and related services. Its current portfolio includes Revio and Vega for long-read HiFi sequencing, and Onso for short-read sequencing. Revio targets large-scale projects and high-throughput genome analysis, while Vega is positioned as a benchtop long-read solution for labs seeking a simpler workflow and fast, high-quality data generation. Onso extends the portfolio into short-read applications. This combination gives PacBio a differentiated offering across multiple sequencing workflows, while reinforcing its core identity as a precision genomics company.